Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
70,578,680
-
Share change
-
+2,784,267
-
Total reported value
-
$3,959,417,115
-
Put/Call ratio
-
51%
-
Price per share
-
$56.14
-
Number of holders
-
341
-
Value change
-
+$108,533,666
-
Number of buys
-
160
-
Number of sells
-
185
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2022
As of 30 Jun 2022,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
341 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,578,680 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Invesco Ltd., Capital Research Global Investors, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and Champlain Investment Partners, LLC.
This page lists
344
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.